Understanding why people switch from injecting to smoking fentanyl and methamphetamine
Official title: Determinants of transitioning from injecting to smoking fentanyl and methamphetamine and implications for harm reduction implementation
Funded at University of California, San Diego · NIH-10951411 · Data updated 2026-11-12
This study looks at why some people in the San Diego-Tijuana area switch from injecting drugs like fentanyl and methamphetamine to smoking them, and it aims to understand their experiences and the support they need to improve services for those who use drugs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $53,960 |
| NIH project number | 1R36DA061013-01 |
| Project ID | NIH-10951411 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who currently inject drugs or have recently transitioned to smoking drugs in the San Diego-Tijuana area.
✕Less likely to help
Patients who do not use drugs or are not involved in the San Diego-Tijuana border region may not benefit from this research.
What this research studies
This research investigates the reasons behind the transition from injecting to smoking drugs, particularly fentanyl and methamphetamine, among individuals in the San Diego-Tijuana border region. By examining various factors such as personal experiences, peer influences, community resources, and local policies, the study aims to identify trends that can inform better service delivery for people who use drugs. The research will utilize a comprehensive framework to analyze these determinants and their implications for harm reduction strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved harm reduction services and resources for individuals who use drugs, potentially reducing overdose rates and the spread of infectious diseases.
How similar studies have gone: Previous research has shown success in understanding drug use behaviors and harm reduction strategies, indicating that this approach could yield valuable insights.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Eger, William Henry — University of California, San Diego
- Study coordinator: Eger, William Henry
Related research
Other NIH-funded projects on the same topics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
BSMART: A program to help people with HIV quit smoking
A program in HIV care settings tests a proven plan to help people with HIV quit smoking, using quick counseling and a switch to quitting medications.
-
BSMAT: Helping people with HIV quit smoking through routine support
A HIV care program in Botswana aims to help people living with HIV quit smoking using a proven 5A brief intervention plus support medication.
-
Improving treatment for people with HIV who smoke and drink in Nairobi, Kenya
A study tests a new plan to help people with HIV in Nairobi quit smoking and reduce heavy drinking, using a low-cost medicine and counseling.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.